Apollo Medical Holdings, Inc. (AMEH) CEO Kenneth Sim on Q4 2020 Results - Earnings Call Transcript

Apollo Medical Holdings, Inc. (AMEH) Q4 2020 Earnings Conference Call March 10, 2021 5:00 PM ET

Company Participants

Kenneth Sim - Executive Chairman & Co-CEO
Brandon Sim - COO & CTO
Eric Chin - CFO

Conference Call Participants

Eugene Mannheimer - Colliers

Operator

Greetings and welcome to the Apollo Medical Holdings Fourth Quarter and Year End 2020 Financial Results Conference Call. At this time all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, [Indiscernible].

Unidentified Company Representative

Thank you, operator and hello, everyone. Thank you for joining us. The press release announcing Apollo Medical Holdings Inc. results for the fourth quarter and year ended December 31, 2020 is available at the investor section of the company's website at www.apollomed.net. To provide some additional background on these results, the company has made a supplemental deck available on its website. A replay of this broadcast will also be made available on ApolloMed website after the conclusion of this call.

Before we get started, I would like to remind everyone that this conference call and any accompanying information discussed here-in contains certain forward-looking statements within the meaning of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terms such as anticipate, believe, expect, future, plan, outlook and will and include among other things statements regarding the company's guidance for the year ending December 31, 2021.

Continued growth, acquisition strategy, ability to deliver sustainable long-term value, ability to respond to the changing environment, operational focus, strategic growth plans and merger integration efforts, as well as the impact of the 2020 novel corona virus COVID-19 pandemic on the company's business operations and financial results.